Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    KalVista Pharmaceuticals ...

    NASDAQ: KALV · Real-Time Price · USD
    12.76
    -0.28 (-2.15%)
    At close: Jun 17, 2025, 12:45 PM

    KalVista Pharmaceuticals Statistics

    Share Statistics

    KalVista Pharmaceuticals has 49.72M shares outstanding. The number of shares has increased by 17.84% in one year.

    Shares Outstanding

    n/a
    		 49.72M

    Shares Change (YoY)

    n/a
    		 17.84%

    Shares Change (QoQ)

    n/a
    		 0.6%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 38.5M

    Failed to Deliver (FTD) Shares

    n/a
    		 708

    FTD / Avg. Volume

    n/a
    		 0.12%

    Short Selling Information

    The latest short interest is 6.22M, so 12.51% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 6.22M

    Short % of Shares Out

    n/a
    		 12.51%

    Short % of Float

    n/a
    		 14.13%

    Short Ratio (days to cover)

    n/a
    		 12.61

    Valuation Ratios

    The PE ratio is -3.3 and the forward PE ratio is -4.34. KalVista Pharmaceuticals's PEG ratio is -0.12.

    PE Ratio

    n/a
    		 -3.3

    Forward PE

    n/a
    		 -4.34

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 2

    PB Ratio

    n/a
    		 2.02

    P/FCF Ratio

    n/a
    		 -4.66

    PEG Ratio

    n/a
    		 -0.12
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for KalVista Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 9.9, with a Debt / Equity ratio of 0.04.

    Current Ratio

    n/a
    		 9.9

    Quick Ratio

    n/a
    		 9.9

    Debt / Equity

    n/a
    		 0.04

    Debt / EBITDA

    n/a
    		 -0.05

    Debt / FCF

    n/a
    		 -0.08

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-844,293.33

    Employee Count

    n/a
    		 150

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -8.45M

    Effective Tax Rate

    n/a
    		 6.26%

    Stock Price Statistics

    The stock price has increased by 10.32% in the last 52 weeks. The beta is -0.02, so KalVista Pharmaceuticals's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.02

    52-Week Price Change

    n/a
    		 10.32%

    50-Day Moving Average

    n/a
    		 12.37

    200-Day Moving Average

    n/a
    		 10.94

    Relative Strength Index (RSI)

    n/a
    		 52.27

    Average Volume (20 Days)

    n/a
    		 597,031

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -86.17M

    Operating Income

    n/a
    		 -140.44M

    Net Income

    n/a
    		 -126.64M

    EBITDA

    n/a
    		 -134.28M

    EBIT

    n/a
    		 -135.1M

    Earnings Per Share (EPS)

    n/a
    		 -3.44
    Full Income Statement

    Balance Sheet

    The company has 31.79M in cash and 7.32M in debt, giving a net cash position of 24.47M.

    Cash & Cash Equivalents

    n/a
    		 31.79M

    Total Debt

    n/a
    		 7.32M

    Net Cash

    n/a
    		 24.47M

    Retained Earnings

    n/a
    		 -469.73M

    Total Assets

    n/a
    		 275.99M

    Working Capital

    n/a
    		 241.74M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -89.23M and capital expenditures -443K, giving a free cash flow of -89.67M.

    Operating Cash Flow

    n/a
    		 -89.23M

    Capital Expenditures

    n/a
    		 -443K

    Free Cash Flow

    n/a
    		 -89.67M

    FCF Per Share

    n/a
    		 -2.44
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    KALV does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for KALV is $22, which is 68.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $22

    Price Target Difference

    n/a
    		 68.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Nov 22, 2016. It was a backward split with a ratio of 1:14.

    Last Split Date

    n/a
    		 Nov 22, 2016

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:14

    Scores

    Altman Z-Score

    n/a
    		 -1.47

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist